4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0000950170-24-130754
CEO bought 26,500 shares at an average $3.79 ($100,468)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…